6-K
Report of Foreign Issuer
NERVGEN PHARMA CORP. Filed Acc 0001104659-26-128401
Condensed consolidated interim financial statements of
- NERVGEN PHARMA CORP.
From the SEC's structured data for this filing
Loading tm2629739d1_6k.htm…